claimedco.com — the verified startup registry
Uncommon Therapeutics
uncommontherapeutics.com · San Francisco · founded 2024 · team 2 · YC Winter 2025 - Early stage biotech, designed three novel drug candidates entering animal studies · trust 0/4
Using the latest technologies to efficiently build drugs that target the underlying cause of rare uncommon diseases
This dossier was built by Clark from a public scan on 2026-07-04 and is unclaimed. Is this your startup? Claim it.
Verified facts
| Company Name | Uncommon Therapeutics
source: https://uncommontherapeutics.com |
| Tagline | Using the latest technologies to efficiently build drugs that target the underlying cause of rare uncommon diseases
source: https://uncommontherapeutics.com |
| City/Location | San Francisco
source: https://www.ycombinator.com/companies/uncommon-therapeutics |
| Founded Year | 2024
source: https://www.ycombinator.com/companies/uncommon-therapeutics |
| Stage | YC Winter 2025 - Early stage biotech, designed three novel drug candidates entering animal studies
source: https://singularitycapital.us/stories/featured-investment-uncommon-therapeutics |
| Team Size | 2
source: https://www.ycombinator.com/companies/uncommon-therapeutics |
| Founders | Noah Auerhahn (Co-Founder & CEO), Ryan Lim, PhD (Co-Founder & CSO)
source: https://www.ycombinator.com/companies/uncommon-therapeutics |
| Entity Type | Not found in public records
source: Public search - no Delaware registration found |
| Contact Email | noah@uncommontherapeutics.com
source: https://uncommontherapeutics.com |
Open in the registry app →